Ampio Pharm
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Ampio Pharm (AMPE) - Total Liabilities
Latest total liabilities as of December 2023: $2.38 Million USD
Based on the latest financial reports, Ampio Pharm (AMPE) has total liabilities worth $2.38 Million USD as of December 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ampio Pharm - Total Liabilities Trend (2006–2023)
This chart illustrates how Ampio Pharm's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ampio Pharm Competitors by Total Liabilities
The table below lists competitors of Ampio Pharm ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Filinvest Development Coproration
PSE:FDC
|
Philippines | ₱559.56 Billion |
|
ENRTD
OTCQB:ENRTD
|
USA | $282.67K |
|
Advanced Container Technologies Inc
PINK:ACTX
|
USA | $3.33 Million |
Liability Composition Analysis (2006–2023)
This chart breaks down Ampio Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ampio Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ampio Pharm (2006–2023)
The table below shows the annual total liabilities of Ampio Pharm from 2006 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $2.38 Million | +32.07% |
| 2022-12-31 | $1.80 Million | -84.41% |
| 2021-12-31 | $11.54 Million | +115.08% |
| 2020-12-31 | $5.37 Million | -29.00% |
| 2019-12-31 | $7.56 Million | -14.06% |
| 2018-12-31 | $8.79 Million | -82.23% |
| 2017-12-31 | $49.49 Million | +610.93% |
| 2016-12-31 | $6.96 Million | -44.27% |
| 2015-12-31 | $12.49 Million | +159.71% |
| 2014-12-31 | $4.81 Million | +71.54% |
| 2013-12-31 | $2.80 Million | +39.00% |
| 2012-12-31 | $2.02 Million | +17.09% |
| 2011-12-31 | $1.72 Million | -63.70% |
| 2010-12-31 | $4.75 Million | +4617.84% |
| 2009-12-31 | $100.60K | +30.98% |
| 2008-12-31 | $76.80K | +75.62% |
| 2007-12-31 | $43.73K | +331.19% |
| 2006-12-31 | $10.14K | -- |